Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11-12
|
pubmed:dateCreated |
1977-3-15
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0007-0947
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
30
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
232-3
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1008987-Ancrod,
pubmed-meshheading:1008987-Antibody Formation,
pubmed-meshheading:1008987-Drug Resistance,
pubmed-meshheading:1008987-Endopeptidases,
pubmed-meshheading:1008987-Humans,
pubmed-meshheading:1008987-Male,
pubmed-meshheading:1008987-Middle Aged,
pubmed-meshheading:1008987-Thromboembolism,
pubmed-meshheading:1008987-Time Factors
|
pubmed:articleTitle |
Acquired resistance to prolonged treatment with intravenous "Arvin" (ancrod).
|
pubmed:publicationType |
Journal Article,
Case Reports
|